-100% Gross Margin 116.33 120.29 -3% % Gross Margin 29.6% 28.5% 1% % Gross Margin (exclude non-recurring cost) 29.6% 30.4% -1% Administrative Expenses before Adj. 39.49 41.45 -5% Adj. staff benefit
% Cost of hospital operations before adj. 294.32 274.71 7% 579.74 532.07 9% Adj. staff benefit 8.15 - 8.15 - Gross margin 120.29 108.76 11% 280.74 234.33 20% % Gross margin 28% 28% 0% 32% 31% 2% % Gross
comfortable triple digit territory. IVL stands to benefit from margin expansion with the resumption of production of EO-EG since June 2017. The commercialization of the ethylene cracker scheduled for later
$ 53.8 million and a deferred tax income of US$ 14.5 million). IVL stands to benefit from expected PET margin expansion. The completion of the ethylene cracker, the new HVA films business and
interest rate. Moreover, ACAP obtains benefit from the lower interest margin rate. This case is in the process of inquiry by the inquiry official. SEC Act S.281/2 paragraph 1 in conjunction with 89/7 or
caused damage to GSC or others obtained benefit. In this regard, they jointly decided, approved, or ordered GSC to grant 7 loans to Asia Capital Group Public Company Limited ("ACAP"), a GSC’s
caused damage to GSC or others obtained benefit. In this regard, they jointly decided, approved, or ordered GSC to grant 7 loans to Asia Capital Group Public Company Limited ("ACAP"), a GSC’s
caused damage to GSC or others obtained benefit. In this regard, they jointly decided, approved, or ordered GSC to grant 7 loans to Asia Capital Group Public Company Limited ("ACAP"), a GSC’s
caused damage to GSC or others obtained benefit. In this regard, they jointly decided, approved, or ordered GSC to grant 7 loans to Asia Capital Group Public Company Limited ("ACAP"), a GSC’s
caused damage to GSC or others obtained benefit. In this regard, they jointly decided, approved, or ordered GSC to grant 7 loans to Asia Capital Group Public Company Limited ("ACAP"), a GSC’s